OptimizeRx Digital Health Platform Adds More than 300 Epic and Cerner Health Systems
09 Juni 2020 - 2:31PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies, payers, providers, and
patients, has finalized a new partnership that expands its digital
communication platform by more than 300 health systems and 75,000
healthcare providers that utilize market-leading EHRs Epic and
Cerner.
Healthcare providers within these health systems will now have
instant access to real-time patient savings information via
OptimizeRx’s cloud-based platform as they are evaluating and
prescribing treatments.
Linked to as much as $528 billion in avoidable healthcare costs
annually, medication non-adherence is a focal point of healthcare
industry performance improvement efforts.
High out-of-pocket prescription drug costs drives non-adherence
even in good economic times. With 33% of Americans delaying
treatment due to cost in 2019, this percentage is likely to rise
given the current COVID-19 related economic challenges. Increased
price transparency within the provider daily workflow is one area
of improvement that can make a difference in treatment
adherence.
“Especially in these challenging times, patients need help with
the cost of healthcare,” commented Miriam Paramore, president of
OptimizeRx. “Often patients cannot afford their medications and
therefore never get them. We are focused on expanding our network
to every EHR, so that every provider and every patient can easily
access the prescription savings that are available on every drug.
This expansion of our network reach is a huge step that will
connect us to an additional 120 million patients, given the market
dominance of Epic and Cerner.”
The OptimizeRx platform now reaches more than 675,000
prescribers directly within their existing digital workflows,
simplifying communication and improving transparency. The expansion
represents an 11% growth for the nation’s largest
point-of-prescribe network, which has traditionally been focused on
the ambulatory care setting.
“As we start to approach 2021 planning with our clients, the
increased need for access to point-of-care communication with
affordability tools for physicians and patients has never been so
critical,” said Will Febbo, CEO of OptimizeRx. "This further
expansion into Epic and Cerner systems builds on previous
integrations and gives us additional scale in the inpatient care
setting. From within provider workflow, we are able to
provide information to support the necessary financial discussions
between physicians and patients when selecting treatment.”
For more information on OptimizeRx, its products or other news,
visit www.optimizerx.com.
About OptimizeRx
OptimizeRx Corporation (NASDAQ: OPRX) is a digital health
company that facilitates communication at point-of-care among all
stakeholders in healthcare. Primarily focused on life science and
payer clients, its suite of digital and mobile SaaS-based solutions
enables affordability, patient adherence and care management.
OptimizeRx’s network reaches more than 60% of U.S. ambulatory
providers, delivering therapeutic support on specialty medications
and patient financial assistance directly within a provider’s
workflow through leading electronic health platforms. OptimizeRx’s
fully integrated platform supports the real-time exchange of
information, improving provider knowledge and patient engagement,
and ultimately leading to healthier outcomes.
For more information, follow the company on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
Statements
This press release contains forward-looking statements within
the definition of Section 27A of the Securities Act of 1933, as
amended, and such as in section 21E of the Securities Act of 1934,
as amended. These forward-looking statements should not be used to
make an investment decision. The words 'estimate,' 'possible' and
'seeking' and similar expressions identify forward-looking
statements, which speak only as to the date the statement was made.
The company undertakes no obligation to publicly update or revise
any forward-looking statements, whether because of new information,
future events, or otherwise. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted, or quantified. Future events and actual results could
differ materially from those set forth in, contemplated by, or
underlying the forward-looking statements. The risks and
uncertainties to which forward-looking statements are subject
include, but are not limited to, the effect of government
regulation, competition and other material risks.
OptimizeRx Contact Doug
Baker, CFOTel (248) 651-6568 (x807)dbaker@optimizerx.com
Media Relations Contact Maira Alejandra,
Media Relations ManagerTel (754) 245-7070
malejandra@optimizerx.com
Investor Relations Contact Ron Both,
CMA Tel (949) 432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024